News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,597 Results
Type
Article (8023)
Company Profile (141)
Press Release (479433)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166743)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238195)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (495)
Accelerated approval (29)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33156)
ALS (117)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (312)
Approvals (10462)
Artificial intelligence (354)
ASCO (160)
Autoimmune disease (233)
Automation (33)
Bankruptcy (263)
Belgium (4)
Best Places to Work (6958)
BIO (36)
Biologics (29)
BIOSECURE Act (1)
Biosimilars (123)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (12)
Bladder cancer (142)
Brain cancer (34)
Breast cancer (534)
Cancer (3931)
Cardiovascular disease (235)
Career advice (246)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (28)
Celiac Disease (3)
Cell therapy (506)
Cervical cancer (36)
Clinical research (48344)
Collaboration (1343)
Commercialization (20)
Compensation (1605)
Complete response letters (36)
COVID-19 (768)
CRISPR (68)
C-suite (846)
Cystic fibrosis (89)
Data (6228)
Denatured (4)
Depression (108)
Dermatology (95)
Diabetes (377)
Diagnostics (4249)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (168)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (174)
Earnings (73865)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88566)
Executive appointments (733)
Eye disease (3)
FDA (12644)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (990)
Gene editing (131)
Generative AI (13)
Gene therapy (347)
GLP-1 (307)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9385)
Hematology (94)
HIV (56)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (74)
Immunology and inflammation (113)
Immuno-oncology (67)
Indications (177)
Infectious disease (969)
Inflammatory bowel disease (140)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (41)
IPO (12396)
IRA (2)
Job creations (1968)
Job search strategy (236)
JPM (1)
Kidney cancer (19)
Kidney disease (67)
Layoffs (59)
Legal (5195)
Licensing (41)
Liver cancer (46)
Longevity (23)
Lung cancer (566)
Lung diease (8)
Lymphoma (266)
Machine learning (29)
Management (3)
Manufacturing (611)
Marketing (17)
MASH (121)
Medical affairs (2)
Medical device (8708)
Medtech (8884)
Mergers & acquisitions (14448)
Metabolic disorders (761)
mRNA (70)
Multiple sclerosis (110)
Multispecific (2)
NASH (4)
Netherlands (1)
Neurodegenerative disease (239)
Neuropsychiatric disorders (40)
Neuroscience (1922)
Neurotech (2)
NextGen: Class of 2026 (3151)
Non-profit (844)
Now hiring (1)
Obesity (239)
Opinion (10)
Ovarian cancer (176)
Pain (186)
Pancreatic cancer (226)
Parkinson's disease (216)
Partnered (12)
Patents (522)
Patient advocacy (2)
Patient recruitment (547)
Patient selection (33)
Peanut (33)
People (41493)
Peptides (13)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15600)
Phase 2 (21600)
Phase 3 (14574)
Pipeline (8266)
Policy (18)
Postmarket research (1570)
Preclinical (6583)
Press Release (34)
Prostate cancer (202)
Psychedelics (10)
Radiopharmaceuticals (203)
Rare diseases (620)
Real estate (3024)
Recruiting (6)
Regenerative medicine (11)
Regulatory (15151)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (46)
RNA editing (8)
RSV (49)
Schizophrenia (109)
Series A (173)
Series B (126)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2022)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (54)
Tariffs (1)
Vaccines (347)
Venture capital (17)
Weight loss (77)
Wet AMD (3)
Women's health (97)
Date
Today (78)
Last 7 days (384)
Last 30 days (1581)
Last 365 days (19174)
2026 (15225)
2025 (19251)
2024 (22988)
2023 (26539)
2022 (34588)
2021 (37169)
2020 (33472)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (318)
Arkansas (12)
Asia (18029)
Australia (2116)
California (12784)
Canada (3340)
China (565)
Colorado (523)
Connecticut (444)
Delaware (222)
Europe (24776)
Florida (1921)
Georgia (405)
Hawaii (3)
Idaho (46)
Illinois (764)
India (58)
Indiana (330)
Iowa (18)
Japan (446)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1266)
Massachusetts (8361)
Michigan (321)
Minnesota (590)
Mississippi (4)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (132)
New Hampshire (60)
New Jersey (2815)
New Mexico (12)
New York (2995)
North Carolina (1356)
North Dakota (4)
Northern California (6468)
Ohio (302)
Oklahoma (14)
Oregon (17)
Pennsylvania (2377)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (80)
South Dakota (1)
Southern California (5325)
Tennessee (128)
Texas (2110)
United States (41427)
Utah (389)
Vermont (1)
Virginia (165)
Washington D.C. (39)
Washington State (983)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,597 Results for "locana inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Business
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer
Locana, Inc., a leading RNA-targeting gene therapy company, announced the appointment of Micah Mackison, as Chief Business Officer.
April 1, 2020
·
2 min read
Business
Locana appoints Kathie Bishop, Ph.D., as Chief Scientific Officer
Locana, a leading RNA-targeting gene therapy company, today announced the appointment of Kathie M. Bishop, Ph.D. as chief scientific officer.
September 4, 2019
·
3 min read
Biotech Beach
Gene Therapy Company Locana Earns $55 Million in Series A Financing
San Diego-based Locana will develop RNA-targeting gene therapy programs.
May 23, 2019
·
2 min read
·
Alex Keown
Business
MDA Awards Venture Philanthropy Grant to Locana to Develop Novel Treatment for Muscular Dystrophy
The Muscular Dystrophy Association and Locana, a leading RNA-targeting gene therapy company, announced the award of an MDA Venture Philanthropy grant totaling $550,000 to advance Locana’s development program for myotonic dystrophy.
June 12, 2019
·
3 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Biotech Beach
Locana Raises $55 Million Series A Financing to Advance Portfolio of RNA-targeting Gene Therapies
Locana, Inc. announced the close of a $55 million Series A financing led by ARCH Venture Partners with participation from Temasek and Lightstone Ventures, all existing investors.
May 22, 2019
·
4 min read
Business
Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer
Locana, Inc. announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding the experienced leadership team and as part of a planned transition of the company’s director and recent CEO, Jeffrey M. Ostrove, Ph.D., to continue service as director..
December 10, 2019
·
2 min read
Press Releases
Medtronic Completes Separation of MiniMed Group, Inc.
October 15, 2026
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
1 of 48,760
Next
